Search
Search Results
##search.searchResults.foundPlural##
-
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2755PDF: 978HTML: 627 -
CAR-T cells microscopic and phenotypic identification in the peripheral blood CAR-T cells in the PB
1792PDF: 689HTML: 222 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9279PDF: 6182HTML: 88048Fig.1b: 212Fig.1c: 219Fig.2a: 203Fig.2b: 198Fig.4: 225Fig.2c: 202Fig.3: 206Tab.1: 256Tab.2: 236Tab.3: 218Tab.4: 250Fig1a: 213 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3774PDF: 1291HTML: 3918Untitled: 250Untitled: 286 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2434PDF: 1899HTML: 163 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1954PDF: 857HTML: 252 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4904PDF: 1855HTML: 2864Untitled: 245 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3234PDF: 961HTML: 2710 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1835PDF: 607HTML: 343 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2481PDF: 1214HTML: 281 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1399PDF: 610Suppl. Files: 368HTML: 172 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1757PDF: 1306HTML: 577 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1968PDF: 815HTML: 562 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1344PDF: 614HTML: 4011 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7790PDF: 2473HTML: 2113Table 1.: 239Table 2.: 249Table 3.: 232Table 4.: 226 -
DISTRIBUTION OF DIFFERENT PML/RAR? BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION
1570PDF: 941HTML: 2251Response to reviewers comments: 204 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
3977PDF: 1125HTML: 909 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1305PDF: 544HTML: 23130 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3730PDF: 1707HTML: 2689 -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: THE EXPERIENCE IN CHINA
2431PDF: 878HTML: 2202New table Chinese children with APL: 178 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1521PDF: 939Suppl. Files: 470HTML: 293 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1447HTML: 634PDF: 869 -
EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome
982PDF: 711HTML: 172 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3378PDF: 1278HTML: 2363 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2283PDF: 844HTML: 1696Figure 1: 218Table 1: 232 -
PATIENTS WITH HAEMOGLOBINOPATHIES AND CHRONIC HEPATITIS C: A REALLY DIFFICULT TO TREAT POPULATION IN 2016?
2991PDF: 1010HTML: 2114Cover letter: 194







